Market Tracker

08/26 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

20.66
Delayed Data
As of Aug 26
 +0.03 / +0.15%
Today’s Change
19.10
Today|||52-Week Range
46.24
-52.13%
Year-to-Date

Today’s Trading

Previous close20.63
Today’s open20.70
Day’s range20.50 - 21.14
Volume861,412
Average volume (3 months)1,305,095
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-34.95%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+4.25%
P/E ratio12.1
Price/Sales2.98
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.21+0.64%
VIVOMeridian Bioscience ...-0.01-0.05%
QDELQuidel Corp+0.17+0.79%
NEOGNeogen Corp+0.28+0.48%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts